AU2002218337A1 - Method for inducing cognition enhancement by use of trimethyl-bicyclo(2.2.1)heptane derivatives - Google Patents

Method for inducing cognition enhancement by use of trimethyl-bicyclo(2.2.1)heptane derivatives

Info

Publication number
AU2002218337A1
AU2002218337A1 AU2002218337A AU1833702A AU2002218337A1 AU 2002218337 A1 AU2002218337 A1 AU 2002218337A1 AU 2002218337 A AU2002218337 A AU 2002218337A AU 1833702 A AU1833702 A AU 1833702A AU 2002218337 A1 AU2002218337 A1 AU 2002218337A1
Authority
AU
Australia
Prior art keywords
bicyclo
trimethyl
cognition enhancement
heptane derivatives
inducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002218337A
Inventor
Outi Maki-Ikola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Oyj filed Critical Orion Oyj
Publication of AU2002218337A1 publication Critical patent/AU2002218337A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
AU2002218337A 2000-11-28 2001-11-27 Method for inducing cognition enhancement by use of trimethyl-bicyclo(2.2.1)heptane derivatives Abandoned AU2002218337A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/722,262 US6335371B1 (en) 2000-11-28 2000-11-28 Method for inducing cognition enhancement
US09722262 2000-11-28
PCT/FI2001/001031 WO2002043726A1 (en) 2000-11-28 2001-11-27 Method for inducing cognition enhancement by use of trimethyl-bicyclo[2.2.1]heptane derivatives

Publications (1)

Publication Number Publication Date
AU2002218337A1 true AU2002218337A1 (en) 2002-06-11

Family

ID=24901109

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002218337A Abandoned AU2002218337A1 (en) 2000-11-28 2001-11-27 Method for inducing cognition enhancement by use of trimethyl-bicyclo(2.2.1)heptane derivatives

Country Status (3)

Country Link
US (1) US6335371B1 (en)
AU (1) AU2002218337A1 (en)
WO (1) WO2002043726A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589996B2 (en) 2000-03-17 2003-07-08 Orion Corporation Treatment of disorders relating to the serotonergic system
US20040082665A1 (en) * 2001-01-22 2004-04-29 Outi Maki-Ikola Method for treating stress or tension
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
AU2003274185A1 (en) * 2002-10-23 2004-05-13 Orion Corporation New uses of deramciclane
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
HUP0301906A3 (en) * 2003-06-23 2006-03-28 Egis Gyogyszergyar Nyilvanosan Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity
EP1500391A1 (en) * 2003-07-24 2005-01-26 Neuro3D Therapeutic use of bicycloheptane derivatives
US20050096349A1 (en) * 2003-11-03 2005-05-05 University Of Florida Methods to prevent or ameliorate medication-, procedure-or stress-induced cognitive and speech dysfunction and methods to optimize cognitive and speech functioning
CZ2006628A3 (en) * 2004-03-12 2007-01-24 Egis Gyogyszergyár Nyrt. Combined pharmaceutical composition for inhibition of decline of cognitive functions
HU227813B1 (en) * 2005-07-14 2012-03-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Pharmaceutical composition for the treatment of psychosis
US11478467B2 (en) 2017-05-04 2022-10-25 Sreenivasarao Vepachedu Targeted drug rescue with novel compositions, combinations, and methods thereof
CA3138116A1 (en) * 2017-05-04 2018-11-08 Exciva GmbH Novel compositions, combinations, and methods thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652270A (en) 1994-07-01 1997-07-29 Egis Gyogyszergyar Rt Pharmaceutical compositions containing bicycloheptane ether amines and a process for the preparation thereof
WO2000064441A2 (en) * 1999-04-28 2000-11-02 Respiratorius Ab Compound for use as a medicament for treatment of disorders involving bronchocontraction
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane

Also Published As

Publication number Publication date
WO2002043726A1 (en) 2002-06-06
US6335371B1 (en) 2002-01-01

Similar Documents

Publication Publication Date Title
AU2002224927A1 (en) Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU2001249881A1 (en) Method of treating the heart
AU2001252638A1 (en) Process for the preparation of 2-halobenzoic acids
AU2001233081A1 (en) Composition for treatment of stress
AU2002218337A1 (en) Method for inducing cognition enhancement by use of trimethyl-bicyclo(2.2.1)heptane derivatives
AU2001286983A1 (en) Method of treatment
AU2001285747A1 (en) Method for the treatment of tobacco
AU2001242364A1 (en) Process for the epoxidation of olefins
AU2002217866A1 (en) Geldanamycin derivatives useful for the treatment of cancer
AU2001273762A1 (en) Process for the preparation of (r)-2-alkyl-3-phenyl-1-propanols
AU2002330042A1 (en) Process for the preparation of 1,5-diarylpyrazoles
PL369718A1 (en) Process for the preparation of (1,4,5)-oxadiazepine derivatives
AU2002214954A1 (en) Process for the preparation of phenylphenol compounds
AU2001262177A1 (en) Method of treatment
AU2002329441A1 (en) Process for the preparation of 3 - isochromanone
AU2000261768A1 (en) An improved process for the preparation of docetaxel
AU2002358085A1 (en) Process for the preparation of 4-methyl-7-aminoquinolones
AU2002340038A1 (en) Method for the selective removal of acyl-functionality attached to the 2'-hydroxy-group of paclitaxel-related derivatives
AU2001235448A1 (en) Process for the epoxidation of olefins
AU2000279379A1 (en) An improved process for the preparation of 10h-phenoxazine
AU2000258438A1 (en) An improved process for the preparation of acylferrocenes
AU2002324291A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
AU2002218338A1 (en) Treatment of psychiatric disorders with trimethyl-bicyclo(2.2.1)heptane derivatives
AU2001237790A1 (en) Method for the preparation of (s)-2-acetylthio-3-phenylpropionic acid